Computed Tomography: Clinical Trials

423 recruiting, 299 active not recruiting, 186 completed, 68 terminated. 588 Phase 2, 305 Phase 1, 141 Phase 3, 122 Not applicable, 42 Early Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	588	Recruiting 246, Active not recruiting 181, Completed 60, Not yet recruiting 33, Withdrawn 27, Terminated 22, Suspended 16, Unknown 2, Enrolling by invitation 1
Phase 1	305	Recruiting 124, Active not recruiting 81, Completed 25, Terminated 24, Withdrawn 21, Not yet recruiting 15, Suspended 14, Unknown 1
Phase 3	141	Recruiting 60, Active not recruiting 53, Not yet recruiting 10, Completed 6, Suspended 5, Terminated 4, Enrolling by invitation 1, Unknown 1, Withdrawn 1
Not applicable	122	Completed 50, Recruiting 20, Active not recruiting 16, Unknown 16, Terminated 9, Withdrawn 6, Not yet recruiting 4, Suspended 1
Early Phase 1	42	Completed 17, Recruiting 13, Active not recruiting 5, Terminated 5, Unknown 1, Withdrawn 1
Phase 4	5	Recruiting 2, Unknown 2, Terminated 1

Follow Computed Tomography: new trials by email Literature Review of Computed Tomography trials Research Report on Computed Tomography

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial Biospecimen Collection, Cisplatin, Computed Tomography - Resectable Intrahepatic Cholangiocarcinoma	Phase 2	Not yet recruiting	Northwestern University	44	2027-12-10	2026-06-10
Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Biospecimen Collection, Computed Tomography, Futibatinib - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8	Phase 1	Not yet recruiting	Northwestern University	18	2027-09-09	2026-10-20
Zanubrutinib and Sonrotoclax for the Treatment of Relapsed Chronic Lymphocytic Leukemia /Small Lymphocytic Leukemia, ZeuS-2 Trial Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Phase 2	Not yet recruiting	City of Hope Medical Center	44	2027-08-04	2026-09-10
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study") Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - AIDS-Related Diffuse Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified	Phase 1	Recruiting	National Cancer Institute (NCI)	15	2027-07-05	2026-11-05
Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography - Recurrent Ganglioneuroblastoma, Recurrent Neuroblastoma	Phase 1 / Phase 2	Recruiting	National Cancer Institute (NCI)	76	2027-06-25	2026-11-06
Removing the Planning Tumor Volume From Radiation Therapy for the Treatment of Head and Neck Squamous Cell Carcinoma Chemotherapy, Computed Tomography, Endoscopic Procedure - Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8	Not applicable	Not yet recruiting	City of Hope Medical Center	30	2027-06-22	2026-11-09
Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer Biospecimen Collection, Carboplatin, Computed Tomography - Lung Non-Squamous Non-Small Cell Carcinoma	Phase 2	Not yet recruiting	Jonsson Comprehensive Cancer Center	16	2027-06-01	2026-02-05
Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse Biospecimen Collection, Bone Marrow Biopsy, Carfilzomib - Recurrent Multiple Myeloma, Refractory Multiple Myeloma	Phase 2	Recruiting	National Cancer Institute (NCI)	80	2027-05-22	2026-11-04
Study to Test Shorter Duration Chemoradiation Therapy Versus Standard Duration Chemoradiation Therapy for Cervical Cancer Biospecimen Collection, Brachytherapy, Cisplatin - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma	Phase 3	Not yet recruiting	NRG Oncology	550	2027-05-19	2026-11-10
Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial Balstilimab, Biospecimen Collection, Botensilimab - Clear Cell Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v8	Phase 2	Recruiting	National Cancer Institute (NCI)	16	2027-05-17	2026-10-21
Lenalidomide and Cosibelimab for the Treatment of Relapsed/Refractory Mycosis Fungoides or Sézary Syndrome Biospecimen Collection, Computed Tomography, Cosibelimab - Recurrent Mycosis Fungoides, Recurrent Sezary Syndrome	Phase 1	Not yet recruiting	City of Hope Medical Center	14	2027-05-16	2026-11-09
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information Biospecimen Collection, Chest Radiography, Computed Tomography - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8	Phase 2	Recruiting	Children's Oncology Group	51	2027-05-15	2026-09-24
CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP Trial Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver	Phase 1	Not yet recruiting	City of Hope Medical Center	36	2027-05-06	2026-09-25
Enfortumab Vedotin for the Treatment of Unresectable or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer, Anaplastic Thyroid Cancer, Medullary Thyroid Cancer, or NUT Carcinoma Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Differentiated Thyroid Gland Carcinoma, Metastatic NUT Carcinoma	Phase 2	Not yet recruiting	Northwestern University	56	2027-05-05	2026-10-07
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Aspiration - Plasma Cell Leukemia	Phase 2	Recruiting	National Cancer Institute (NCI)	74	2027-04-20	2026-10-26
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma Autologous BAFFR-targeting CAR T Cells, Biospecimen Collection, Bone Marrow Aspiration - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma	Phase 1	Recruiting	City of Hope Medical Center	16	2027-04-17	2026-11-13
Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Multiple Myeloma, Refractory Multiple Myeloma	Phase 1 / Phase 2	Recruiting	National Cancer Institute (NCI)	162	2027-04-12	2026-10-16
Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma Biospecimen Collection, Computed Tomography, Positron Emission Tomography - Recurrent Plasmablastic Lymphoma, Refractory Plasmablastic Lymphoma	Phase 1	Recruiting	National Cancer Institute (NCI)	30	2027-03-26	2026-10-20
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis Biopsy Procedure, Biospecimen Collection, Breast Conservation Treatment - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma	Phase 3	Recruiting	SWOG Cancer Research Network	562	2027-03-09	2026-10-13
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial Atezolizumab, Atezolizumab and Recombinant Human Hyaluronidase, Biospecimen Collection - Lung Non-Small Cell Carcinoma	Phase 3	Recruiting	National Cancer Institute (NCI)	336	2027-03-02	2026-11-05

Showing 20 of 1158. Sign in to see all of them.

Conditions studied

Lung Neoplasms (115)  ·  Prostatic Neoplasms (103)  ·  Carcinoma, Non-Small-Cell Lung (82)  ·  Neoplasm Metastasis (59)  ·  Carcinoma, Renal Cell (49)  ·  Breast Neoplasms (48)  ·  Pancreatic Neoplasms (46)  ·  Melanoma (40)  ·  Multiple Myeloma (39)  ·  Lymphoma, Large B-Cell, Diffuse (38)  ·  Colorectal Neoplasms (37)  ·  Squamous Cell Carcinoma of Head and Neck (37)  ·  Carcinoma, Hepatocellular (33)  ·  Ovarian Neoplasms (32)  ·  Urinary Bladder Neoplasms (32)

Sponsors

National Cancer Institute (NCI) (356)  ·  Mayo Clinic (110)  ·  City of Hope Medical Center (88)  ·  University of Washington (47)  ·  Jonsson Comprehensive Cancer Center (45)  ·  M.D. Anderson Cancer Center (41)  ·  Fred Hutchinson Cancer Center (27)  ·  Roswell Park Cancer Institute (27)  ·  Emory University (24)  ·  NRG Oncology (24)  ·  Alliance for Clinical Trials in Oncology (21)  ·  Children's Oncology Group (20)  ·  Northwestern University (20)  ·  SWOG Cancer Research Network (20)  ·  Ohio State University Comprehensive Cancer Center (18)

Countries

United States (1035)  ·  Canada (97)  ·  Puerto Rico (58)  ·  Australia (28)  ·  New Zealand (13)  ·  France (11)  ·  United Kingdom (11)  ·  Hong Kong (10)  ·  Guam (8)  ·  South Korea (8)  ·  China (7)  ·  Ireland (6)  ·  Italy (6)  ·  Japan (6)  ·  Saudi Arabia (6)

Top investigators

Jeremie Calais (8)  ·  A P Chen (7)  ·  Jeremie Calais, MD (6)  ·  Andrei Iagaru (5)  ·  Ibrahim Aldoss (5)  ·  Andrea B Apolo (4)  ·  Arya Amini (4)  ·  Haider S Mahdi (4)  ·  Jason M Johnson (4)  ·  Jeffrey Y Wong (4)  ·  Joyce F Liu (4)  ·  Marwan G Fakih (4)  ·  Mengyang Di, MD, PhD (4)  ·  Michael Schweizer (4)  ·  Patricia M LoRusso (4)

Results publications

PMID 37185961, PMID 41698328, PMID 37505794, PMID 31401903, PMID 33602654, PMID 35031545, PMID 35175355, PMID 37222189, PMID 38421243, PMID 39571596, PMID 40135712, PMID 40966692, PMID 41747891, PMID 41911908, PMID 42335416, PMID 10813118, PMID 11458060, PMID 11851836, PMID 12949715, PMID 15249451, PMID 16234512, PMID 16361632, PMID 16461844, PMID 16519642, PMID 16848811, PMID 1694805, PMID 17179104, PMID 17416851, PMID 17515464, PMID 17882490, PMID 17940305, PMID 18289575, PMID 18381378, PMID 18824760, PMID 18849011, PMID 19019414, PMID 19034598, PMID 19307121, PMID 19391065, PMID 19442889, PMID 19616793, PMID 19766264, PMID 20197669, PMID 20379145, PMID 20404381, PMID 20975002, PMID 21075551, PMID 21543687, PMID 21723515, PMID 21999863

NIH funding

P30CA033572 (85), U10CA180820 (71), U10CA180868 (57), U10CA180888 (50), U10CA180821 (39), U10CA180886 (33), P30CA060553 (28), UM1CA186689 (24), P30CA138292 (23), UM1CA186691 (19), UM1CA186709 (19), UM1CA186712 (16), UM1CA186690 (14), UM1CA186717 (14), P30CA014089 (13)